Richard M. Glickman

Director, Essa Pharma (United States).

Companies

enGene Therapeutics Inc.Board member Oct 31, 2023 to now¹
Essa Pharma (United States)Board member Oct 1, 2020 to now²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

enGene Therapeutics Inc. ENGN24,675 shares³$40.5K at $1.64May 28, 2024
Essa Pharma (United States)0 shares⁴Oct 9, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Oct 9, 2025Returned to company 43,240 shares of Essa Pharma (United States)⁴
May 28, 2024Exercised options 120 shares at $0.89 of enGene Therapeutics Inc.³
Apr 24, 2024Exercised options 3,750 shares at $4.90 of Essa Pharma (United States)⁵
Oct 31, 2023Granted 24,555 shares of enGene Therapeutics Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARenGene Therapeutics Inc., Board member
2
SEC EDGAREssa Pharma (United States), Board member
3
SEC EDGARenGene Therapeutics Inc. shares after the filing of May 28, 2024
4
SEC EDGAREssa Pharma (United States) shares after the filing of Oct 9, 2025
5
SEC EDGARForm 4 filed Apr 25, 2024
6
SEC EDGARForm 4 filed Nov 2, 2023